Login to Your Account



Drug Discovery Alliance Aims To Boost Translational Hit Rate

By Marie Powers
BioWorld Today Staff Writer

Monday, February 4, 2013

The move by six major drug discovery and development organizations to codify relationships that have existed for many years signals growing frustration in academia about the dearth of venture capital funding and big pharma support for early stage therapeutic development. Launch of the Global Alliance of Leading Drug Discovery and Development Centres represents a formal effort by the global institutions to collaborate on drug discovery projects of mutual interest and to improve the translational medicine hit rate.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription